Johnson & Johnson's Animas Corporation, has recalled its Animas 2020 Insulin Pumps. The U.S. Food and Drug Administration (FDA) assigned a Class 1 recall, the most critical of the recall classes. The Animas 2020 Insulin Pumps are used to deliver insulin directly into the patient's bloodstream for treatment of diabetes.  The FDA found a component issue affecting the Animas 2020 Infusion Insulin Pumps that were manufactured between March 1, 2012, to November 30, 2012.  The component issue may trigger a false alarm causing the user to rewind, load and prime the pump. This could lead to an overdose of insulin putting the patient at risk of hypoglycemia or even death. 

Hypoglycemia occurs when blood sugars (glucose) drop too low causing nausea, confused or pass-out. In severe cases, seizures or death may result. 

Our firm is actively investigating claims against the manufacturer of these insulin pumps.  


Matthew L. White
Connect with me
Founder & Partner of Louisville Personal Injury Law Firm Gray & White Law
Comments are closed.